Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Leukemia Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01761890
What this trial is testing

Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 147
Testing effectiveness (Phase 2)Study completedNCT00661180
What this trial is testing

Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to Gleevec

Who this might be right for
Chronic Myelogenous Leukemia
Bayer 10
Not applicableStudy completedNCT03454503
What this trial is testing

Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt

Who this might be right for
Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
Hikma Pharmaceuticals LLC 173
Testing effectiveness (Phase 2)Study completedNCT03734601
What this trial is testing

Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Disorder+6 more
Stanford University 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT05007873
What this trial is testing

ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Chronic Phase Chronic Myelogenous LeukemiaPhiladelphia Chromosome PositiveBCR-ABL1 Positive Chronic Myelogenous Leukemia+1 more
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Looking for participantsNCT06453902
What this trial is testing

TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients

Who this might be right for
Chronic Myeloid LeukemiaAccelerated Phase CML
Shenzhen TargetRx Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT02807272
What this trial is testing

Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myelomonocytic, Chronic
Kura Oncology, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT00003913
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 390
Not applicableStudy completedNCT01490853
What this trial is testing

Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy

Who this might be right for
Chronic Myeloid Leukemia
Università degli Studi di Brescia 116
Not applicableStudy completedNCT03678454
What this trial is testing

Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium

Who this might be right for
Chronic Myeloid LeukemiaCMLPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia+1 more
Incyte Biosciences Benelux 80
Early research (Phase 1)Looking for participantsNCT06401603
What this trial is testing

A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia

Who this might be right for
Advanced Chronic Myeloid LeukemiaPhiladelphia Chromosome-Positive Acute Myeloid Leukemia
M.D. Anderson Cancer Center 30
Not applicableStudy completedNCT02842229
What this trial is testing

Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

Who this might be right for
Myelodysplastic SyndromesLeukemia Myeloid AcuteMultiple Myeloma+1 more
Celgene 117
Testing effectiveness (Phase 2)Study completedNCT00053001
What this trial is testing

Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome

Who this might be right for
AnemiaLeukemiaMyelodysplastic Syndromes+1 more
Fallon Clinic
Post-approval studies (Phase 4)UnknownNCT03873311
What this trial is testing

Azacytidine + HAG Regimen vs. Azacytidine for Elderly Patients With Newly Diagnosed Myeloid Malignancy

Who this might be right for
Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic Leukemia
Shenzhen Second People's Hospital 114
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Early research (Phase 1)Study completedNCT02129101
What this trial is testing

Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies

Who this might be right for
Chronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromeEssential Thrombocythemia+8 more
Mayo Clinic 63
Early research (Phase 1)Not Yet RecruitingNCT06672263
What this trial is testing

A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT00264160
What this trial is testing

Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy

Who this might be right for
Leukemia, Myeloid, Chronic
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT00048672
What this trial is testing

Therapy of Early Chronic Phase CML With Gleevec

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
M.D. Anderson Cancer Center 50
Not applicableEnded earlyNCT01761695
What this trial is testing

Chronic Myelod Leukemia Registry at Asan Medical Center

Who this might be right for
Leukemia, Chronic MyeloidMyeloid Leukemia, Chronic, Accelerated PhaseMyeloid Leukemia, Chronic, Chronic Phase
Asan Medical Center 100
Next Page